AGR2 and pancreatic neoplasm: Deletion of the ER-retention motif enhanced the secretion of AGR2 and injecting this purified AGR2 mutant into the prostate and pancreatic cancer xenograft models increased the metastatic capabilities as compared to wild-type AGR2 [77].